Apollo Medical Devices is developing a handheld blood testing system that will disrupt the existing $2.4 billion point-of-care rapid blood chemistry testing market with a faster and more cost effective solution, that requires only a single drop of blood from the finger. Apollo’s patented technology provides patient blood chemistry test results directly to a portable analyzer at the patient’s bedside.